Loading viewer...
investor_presentation
Format: PDF investor_presentation
First Quarter 2024 Results Swiss Re investor and analyst presentation Zurich, 16 May 2024
First Quarter 2024 Results
Swiss Re investor and analyst presentation
Zurich, 16 May 2024First Quarter 2024 Results
Reinsurance84.7% <87% Combined ratio1
Solutions89.9% <93% Combined ratio2
Reinsurance41 2m ~1.5bn Net income (USD)
Group1 092m >3.6bn Net income (USD)Strong Q1 2024 results, focus on achieving full -year financial targets
1-Insurance service expense (net) / insurance revenue (net)
2-(Insurance service expense (gross) + reinsurance result + non -directly attributable expenses) / insurance revenue (gross)Net income
investments4.0%First Quarter 2024 Results
Favourable contributions from insurance and investment activities
3Group net income (USD bn) New business CSM (USD bn) Insurance revenue (USD bn)
1Including other income/expensesQ1 2024
•Q1 2024 result reflects continued underwriting
discipline, improved price adequacy in both P&C
businesses, a strong investment return, and
effective management of operating expenses•New business CSM driven by P&C Re, given
attractive margins achieved at January 2024
renewals, and robust contribution from L&H Re
•Corporate Solutions impacted by seasonality of
reinsurance program, which largely incepts in Q1,
while new business incepts throughout the year•Insurance revenue supported by strong margins
across both P&C businesses
•L&H Re’s contribution reflects accelerated
earnings recognition and reset of best estimate
liabilities under IFRS 1 7Q1 2024 Q1 20245.0
-0.8Insurance service result
Insurance finance resultInvestment result
Financing costs, taxes & other11.1 1.4
Corporate SolutionsFirst Quarter 2024 ResultsFinancial highlights
Preview truncated — download the full document for the complete content.
conference
26 Pages
Biolase